Guide · Updated November 2026

Copay Accumulators and Maximizers: The GLP-1 Savings Card Catch

Q: Does my state's copay accumulator ban protect my GLP-1 savings card?

Only if your plan is fully insured. Federal ERISA law generally exempts self-funded employer plans from state insurance laws, and most large-employer workers are on self-funded plans.

Q: Does copay assistance for Ozempic or Zepbound count toward my deductible?

It depends on your specific plan's policy. A 2023 court ruling vacated the 2021 federal rule that allowed broad use of accumulators, but HHS said it would not take enforcement action until it issues a new rule.

Q: How do I find out if my plan uses an accumulator or maximizer?

Ask your insurer or benefits administrator directly whether your plan uses a copay accumulator, copay maximizer, or alternative funding program, and whether your plan is self-funded.

Q: Can I do anything if my plan has one of these programs?

Ask your employer's benefits team about opting out for the next plan year, check whether a manufacturer patient-assistance program applies instead of a copay card, and budget as if the card's payments won't count toward your deductible.

About four in ten commercially insured people were in plans using a copay accumulator or copay maximizer as of late 2025, according to a February 2026 Drug Channels analysis of MMIT data. If you're using a manufacturer savings card on Ozempic, Wegovy, Mounjaro, or Zepbound, one of these programs can be quietly running in the background, and it changes whether that card is actually saving you anything toward your deductible.

Neither program shows up on the card itself. You usually find out when your deductible hasn’t moved despite months of “discounted” fills, or when your copay jumps to full price mid-year with no warning.

What a copay accumulator does

A copay accumulator lets the manufacturer’s card reduce what you pay at the pharmacy counter, but your plan doesn’t count that card-covered amount toward your deductible or annual out-of-pocket maximum. Only the cash that comes directly out of your pocket counts.

Take Zepbound’s covered single-dose pen savings card: pay as little as $25, with a maximum of $100 off each monthly fill, $1,300 a year and up to 13 fills. Say your plan charges a $125 copay for a covered fill. The card pays $100 and you pay $25. Under an accumulator, only your $25 counts toward your deductible and out-of-pocket maximum. The card’s $100 doesn’t. Over 13 fills, that’s up to $1,300 of payments that never move your deductible.

The bigger problem shows up when you’re still in your deductible. The pharmacy charge is then much higher than $125, the card still only covers $100, and none of that $100 helps you reach the deductible faster. The card worked as advertised, but your deductible ends the year closer to where it started than you expected.

What a copay maximizer does differently

A maximizer skips the “$25 copay” experience entirely. Instead of letting you see a low advertised price, the plan’s pharmacy benefit manager looks at the card’s total annual benefit and sets your ongoing plan copay at whatever amount captures that subsidy across your fills. You never see $25. You see a higher, calculated copay every month, the card quietly pays its share behind the scenes, and your deductible still doesn’t move, because none of the card’s contribution counts as your cost-sharing either way.

This is an illustration of the mechanics, not a quote from any specific plan’s math. The exact copay a maximizer sets varies by PBM and by which card benefit it’s extracting.

	Copay accumulator	Copay maximizer
What you see at the counter	The card’s advertised low price (e.g., $25) while the card lasts	A calculated copay, usually higher than the card’s advertised price
Does the card still pay	Yes, until its annual cap runs out	Yes, continuously, spread across the plan year
Does it count toward your deductible	No	No
When the surprise hits	When the annual cap runs out and your price jumps	Less of a sudden jump, since the higher copay is already baked in all year

Check the full savings card terms by drug

See Current Card Caps and Terms →

Where the law stands, and why that doesn’t match what plans actually do

The regulatory history here is tangled. Earlier HHS guidance allowed plans to leave manufacturer assistance out of a patient’s cost-sharing only when a medically appropriate generic equivalent was available. That would have protected GLP-1 users, since brand semaglutide and tirzepatide have no generic version. The 2021 federal payment rule loosened that. In 2023, in HIV and Hepatitis Policy Institute v. HHS, a federal court in Washington, DC vacated the 2021 regulations and sent the question back to HHS.

Here’s the catch: in a November 2023 court filing, HHS said it did not intend to take any enforcement action against plans over how they treat manufacturer assistance until it issues a new final rule. The Drug Channels analysis above still found these programs widespread in 2025. In practice, your plan’s own policy is what determines whether your card counts toward your deductible.

Compare providers before you commit to a plan year

Browse the Provider Directory →

State bans exist, but most won’t help if your employer self-funds

In a March 2026 letter to Rhode Island lawmakers, the HIV+Hepatitis Policy Institute said 26 states, DC and Puerto Rico already require private-market insurers to count copay assistance toward a patient’s cost-sharing. That sounds like broad protection. It mostly isn’t, for one structural reason: those state laws apply to fully insured plans, the kind an insurance company itself carries the risk on, and federal ERISA law generally preempts them from reaching self-funded employer plans, where the employer carries the risk and simply hires an administrator to process claims.

Most people with large-employer coverage are in a self-funded plan. The KFF 2025 Employer Health Benefits Survey found 67% of covered workers overall, and 80% at firms with 200 or more workers, are in self-funded plans. Your state’s accumulator ban might not reach you at all, even if your state is one of the ones that passed one. Checking your plan document’s funding type, not just your state’s law, is the only way to know for sure.

How to check your own plan

Call your insurer or your employer’s benefits line and ask directly: “Does my plan use a copay accumulator, copay maximizer, or an alternative funding program?” That’s specific industry language, and a generic “do you cover this drug” question won’t get you the answer. Also ask whether your plan is self-funded, since that determines whether any state ban applies to you.

Your Summary of Benefits and Coverage (SBC) document sometimes lists this under “accumulator adjustment” or “alternative funding program” language, though not every plan discloses it clearly there. If you’ve been using a card for months and your deductible tracker in your insurance portal hasn’t moved, that’s the practical sign a program is already running, regardless of what your SBC says.

Bottom Line

A copay accumulator lets your savings card work at the pharmacy counter without any of it touching your deductible, so the bill jumps once the card’s annual cap runs out. A maximizer skips the low advertised price altogether and sets your copay to capture the same subsidy all year, with the same deductible-tracking problem. About four in ten commercially insured people were in a plan using one of these programs in late 2025, and the state laws meant to stop it mostly don’t reach the self-funded employer plans most large-employer workers are actually on. Ask your plan directly, in those specific terms, rather than assuming your card is doing what the manufacturer’s marketing implies.

FAQ

What’s the difference between a copay accumulator and a copay maximizer?

An accumulator lets you see the card’s advertised low price until its annual cap runs out, then you pay full price with a deductible that barely moved. A maximizer sets a higher calculated copay from the start that captures the same card subsidy spread across the year. Neither counts the card’s contribution toward your deductible.

Does my state’s copay accumulator ban protect my GLP-1 savings card?

Only if your plan is fully insured. Twenty-six states, DC and Puerto Rico have laws for private-market plans, but federal ERISA law generally exempts self-funded employer plans from state insurance laws, and most large-employer workers are on self-funded plans.

Does copay assistance for Ozempic or Zepbound count toward my deductible?

It depends entirely on your specific plan’s policy, not on the drug. A 2023 court ruling vacated the 2021 federal rule that allowed broad use of accumulators, but HHS said it would not take enforcement action until it issues a new rule, so many plans keep running these programs.

How do I find out if my plan uses an accumulator or maximizer?

Ask your insurer or benefits administrator directly: “Does my plan use a copay accumulator, copay maximizer, or alternative funding program?” Also ask whether your plan is self-funded. A deductible that hasn’t moved despite months of card-discounted fills is a practical sign one of these programs is active.

Can I do anything if my plan has one of these programs?

Your options are limited and plan-specific. Ask your employer’s HR or benefits team whether they’ve considered opting out for the next plan year, check whether a manufacturer patient-assistance program (rather than a copay card) might apply to your situation, and budget as if the card’s payments won’t count toward your deductible.

Guides:

Compare: All Providers · All Guides

What we checked

This AI-assisted public-source desk check reviewed Lilly’s Zepbound savings terms, a February 2026 Drug Channels analysis, law-firm summaries of the 2023 court ruling and HHS’s enforcement statement, a March 2026 HIV+Hepatitis Policy Institute letter on state laws and the KFF 2025 Employer Health Benefits Survey on November 4, 2026. This is not a clinical review and it is not medical advice. Prices and policies change, so confirm them with the provider or your prescriber before you act.